The Gut-Heart Axis: Effects of Intestinal Microbiome Modulation on Cardiovascular Disease-Ready for Therapeutic Interventions?
腸道-心臟軸:腸道微生物組調節對心血管疾病的影響—準備好進行治療介入了嗎?
Int J Mol Sci 2025-01-08
Investigation of a targeted panel of gut microbiome-derived toxins in children with chronic kidney disease.
針對慢性腎病兒童的腸道微生物群衍生毒素的目標面板調查。
Pediatr Nephrol 2025-01-17
Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats.
接觸 rotenone 後,代謝肽的失調先於高胰島素血症和炎症在大鼠中的發生。
Cells 2025-01-24
Bile-processed Rhizoma Coptidis alleviates type 2 diabetes mellitus through modulating the gut microbiota and short-chain fatty acid metabolism.
經膽汁處理的黃連(Rhizoma Coptidis)透過調節腸道菌群與短鏈脂肪酸代謝,緩解第二型糖尿病(type 2 diabetes mellitus)。
Int Immunopharmacol 2025-04-20
The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders.
GLP-1 受體促效劑在神經認知障礙中的治療效果與機轉
Ther Adv Neurol Disord 2025-04-28
Correlation Analysis of Gut Microbiota Derivatives with Coronary Artery Disease Severity and Prognosis.
腸道微生物衍生物與冠狀動脈疾病嚴重程度及預後之相關性分析
Rev Cardiovasc Med 2025-05-12
Immune-microbiota dysregulation in maintenance hemodialysis: a 16S rRNA sequencing-based analysis of gut flora and T cell profiles.
維持性血液透析患者的免疫-腸道菌群失調:基於16S rRNA定序的腸道菌相與T細胞特徵分析
Ren Fail 2025-05-15